Perhexiline maleate, a new anti-anginal drug, evaluated by "modified double blind double cross over study". 1974

K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010480 Perhexiline 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. Perhexilene
D010880 Piperidines A family of hexahydropyridines.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
April 1973, Postgraduate medical journal,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
November 1985, Annals of clinical biochemistry,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
June 1978, European journal of clinical pharmacology,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
August 1973, Arquivos brasileiros de cardiologia,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
April 1975, La Clinica terapeutica,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
December 1973, Therapeutique (La Semaine des hopitaux),
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
June 1975, Arquivos brasileiros de cardiologia,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
December 1973, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
September 1972, Geriatrics,
K K Datey, and C P Dalvi, and P N Kelkar, and R K Bhootra
January 1972, The Journal of clinical pharmacology and new drugs,
Copied contents to your clipboard!